Skip to content

Performance Evaluation of Abbott TB Rapid Test

A Multi-centric Performance Evaluation of Diagnostic Accuracy of Determine™ TB LAM Ag Test, a Point-of-Care Urine Lipoarabinomannan Assay, for detection of Active Tuberculosis in People Living with HIV in India - Not Applicable

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064730
Enrollment
330
Registered
2024-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system

Interventions

Control Intervention1: Composite Reference Standard (CRS), i.e., the standard for diagnosis of active TB disease, commonly called the ‘gold’ standard in diagnostic accuracy studies, based on the NTEP

Sponsors

Abbott Diagnostics Medical Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: HIV positive status and CD4 count = 200 cells/ mm3

Exclusion criteria

Exclusion criteria: Individual currently under anti-tuberculosis treatment (ATT)

Design outcomes

Primary

MeasureTime frame
Diagnostic performance evaluation of Determine TB LAM Ag TestTimepoint: This is approximately 12 months study for enrolling 330 patients which we expect to start from 1st of April 2024 and complete on or before Mar 2025 and result analysis will be done within Mar/Apr 2025

Secondary

MeasureTime frame
A point-of-Care urinary LAM assay, for detection of active TB disease in people living with HIV (PLHIV) with CD4 counts less than or equal to 200 cells/mm in IndiaTimepoint: This is approximately 12 months study for enrolling 330 patients which we expect to start from 1st of April 2024 & complete on or before Mar 2025 & result analysis will be done within Mar/Apr 2025

Countries

India

Contacts

Public ContactDr Upasna Agarwal

National Institute Of Tuberculosis and Respiratory Diseases

u.agarwal@nitrd.nic.in01169027100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026